Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

U. of Tennessee team claims novel androgen receptor antagonists

Oct. 13, 2003

GSK antiangiogenic Tie-2 and/or VEGFR2 inhibitors covered by patent

Oct. 13, 2003

Acceptable toxicity profile described for GEM-231 against refractory solid tumors

Oct. 10, 2003

ILX-651 enters new phase II study in melanoma

Oct. 10, 2003

Novel heparanase inhibitors and their use as antitumor agents described in recent patent

Oct. 9, 2003

News-breaking molecule: the first and only reported potent inhibitor of human asparagine synthase

Oct. 9, 2003

Antitumor efficacy and safety of arzoxifene in advanced endometrial cancer

Oct. 8, 2003

Sequential combination therapy reported effective in advanced follicular lymphoma

Oct. 8, 2003

Arius and PDL enter cancer antibody development partnership

Oct. 6, 2003

Rolling NDA submission continues for RSR-13

Oct. 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...